心房功能性二尖瓣反流二尖瓣修复的长期结局
本研究分析2005至2020年单中心1435例二尖瓣修复患者,其中162例为心房功能性二尖瓣反流(AFMR)。中位随访6.1年,5年生存率86%、10年73%,5年和10年免于MR复发率分别为89%和80%。二尖瓣修复可有效治疗AFMR,改善生存并减少MR复发。
要点
- AFMR定义为左心室功能正常、左心房扩大及二尖瓣环扩张。
- 162例AFMR患者二尖瓣修复后5年生存率86%,10年73%。
- 5年和10年免于MR复发率分别为89%和80%。
核心结论
- 二尖瓣修复可有效治疗AFMR,改善生存并减少MR复发。
研究设计与样本
- 单中心分析2005至2020年1435例二尖瓣修复患者,其中162例归类为AFMR。
- AFMR排除标准基于术前超声心动图和手术记录建立。
- 主要结局为总死亡率,次要结局为MR复发(随访超声示中度或以上二尖瓣反流)。
主要发现
- 全队列中位随访6.1年(四分位距3.2-11.2年)。
- AFMR患者5年生存率86%,10年生存率73%。
- 5年和10年免于MR复发率分别为89%和80%。
- 162例患者术前均有中度或以上MR,术后随访期间多数为微量或轻度MR。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atrial functional mitral regurgitation (AFMR), defined by normal left ventricular function, enlarged left atrium, and a dilated mitral valve annulus, has been a concept discussed for >10 years. However, there are still no established guidelines for its treatment in the American College of Cardiology/American Heart Association recommendations. This study aimed to determine the long-term outcomes of mitral annuloplasty as a treatment for AFMR. METHODS: We analyzed 1435 patients who underwent mitral valve repair at our institution between 2005 and 2020, with 162 classified as having AFMR. Exclusion criteria for AFMR were established based on preoperative echocardiography and operative notes. The primary outcome was overall mortality, and the secondary outcome was MR recurrence, which was defined as moderate or greater mitral regurgitation observed on echocardiography during the follow-up period, analyzed using our hospital's medical records and data from the National Statistical Office. RESULTS: The median follow-up duration for the entire patient cohort was 6.1 years (interquartile range, 3.2-11.2 years). Patients had a 5-year survival rate of 86% and a 10-year survival rate of 73%, with freedom from MR recurrence rates of 89% and 80% at 5 and 10 years, respectively. Although all 162 patients had moderate or greater MR before surgery, most experienced trivial or mild MR after mitral valve repair throughout the follow-up period. CONCLUSIONS: In summary, mitral valve repair effectively treats patients with AFMR, addressing survival and mitigating MR recurrence.
引用
- Shin JH, Lee SH, Joo HC, et al. Long-term Outcomes of Mitral Valve Repair for Atrial Functional Mitral Regurgitation. Ann Thorac Surg. 2024. PMID: 39277158. doi:10.1016/j.athoracsur.2024.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。